MYGN - Myriad Genetics, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 51.81B
Enterprise Value 31.95B
Trailing P/E 408.17
Forward P/E 112.12
PEG Ratio (5 yr expected) 10.93
Price/Sales (ttm)2.13
Price/Book (mrq)1.65
Enterprise Value/Revenue 32.29
Enterprise Value/EBITDA 619.02

Trading Information

Stock Price History

Beta (3Y Monthly) 1.40
52-Week Change 3-41.46%
S&P500 52-Week Change 32.12%
52 Week High 350.44
52 Week Low 322.07
50-Day Moving Average 331.79
200-Day Moving Average 330.01

Share Statistics

Avg Vol (3 month) 31.43M
Avg Vol (10 day) 33.37M
Shares Outstanding 573.37M
Float 65.78M
% Held by Insiders 1N/A
% Held by Institutions 1N/A
Shares Short (Jul 31, 2019) 412.49M
Short Ratio (Jul 31, 2019) 418.06
Short % of Float (Jul 31, 2019) 423.18%
Short % of Shares Outstanding (Jul 31, 2019) 417.02%
Shares Short (prior month Jun 28, 2019) 413.88M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 21/2
Last Split Date 3Mar 26, 2009

Financial Highlights

Fiscal Year

Fiscal Year Ends Jun 30, 2019
Most Recent Quarter (mrq)Jun 30, 2019

Profitability

Profit Margin 0.54%
Operating Margin (ttm)3.47%

Management Effectiveness

Return on Assets (ttm)1.35%
Return on Equity (ttm)0.43%

Income Statement

Revenue (ttm)851.1M
Revenue Per Share (ttm)11.58
Quarterly Revenue Growth (yoy)11.10%
Gross Profit (ttm)650.1M
EBITDA 102.5M
Net Income Avi to Common (ttm)4.6M
Diluted EPS (ttm)0.06
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)136.9M
Total Cash Per Share (mrq)1.85
Total Debt (mrq)233.5M
Total Debt/Equity (mrq)21.44
Current Ratio (mrq)2.96
Book Value Per Share (mrq)14.81

Cash Flow Statement

Operating Cash Flow (ttm)83.7M
Levered Free Cash Flow (ttm)59.74M